喀什阴道炎治疗较好的医院(喀什怀孕可以检查多少天吗) (今日更新中)

BEIJING, Jan. 24 (Xinhua) -- China has invested 115 billion yuan (17.45 billion U.S. dollars) on the South-to-North Water Diversion Project as of the end of last year, a senior official said Monday.E Jingping, director of the Office of the South-to-North Water Diversion Project Commission (SNWDPC) of the State Council, said construction on 40 projects began last year, marking a new annual record.No major accidents happened while constructing the projects last year, E said.The South-to-North Water Diversion Project is designed to divert water from the water-rich south of China, mainly the Yangtze, the country's longest river, to the country's arid northern regions. It will consist of three routes: an eastern, middle and western route. The project started with construction of the eastern route in 2002.Up until now, both of the eastern and middle routes were already under construction. The western route, meant to replenish the Yellow River with water from the upper reaches of the Yangtze through tunnels in the high mountains of western China, is still in the planning stage.About 330,000 people in Hubei and Henan Provinces will be relocated before the middle route is completed in 2014.

SHANGHAI, Feb. 8 (Xinhua) - Shanghai World Expo authorities said that about 300,000 tourists have visited the China Pavilion of the expo during the seven-day Spring Festival holiday, as of Tuesday evening.Daily peak was recorded at 48,000 visitors, authorities said late Tuesday.The China Pavilion had been adorned with a new logo of a rabbit and two carrots to mark the country's Lunar New Year celebrationsMore than 1,500 staff, police and volunteers were assigned to the China Pavilion to ensure public safety during the holiday.The organizers also sold tickets in advance and extended opening hours to accommodate the large number of visitors.Overseas and domestic tourists from outside Shanghai comprised 70 percent of the total visitors during the holiday, according to a survey by the organizer.The China Pavilion of the Shanghai World Expo had reopened on December 1, 2010 and will remain open to the public until the end of May this year.

CHENGDU, May 8 (Xinhua) -- As a brand-name herbal capsule for cardiovascular disease in China, Di'ao Xinxuekang only needs to wait for another 15 years before reaching the EU market."The Dutch medical supervisors have recognized it as a qualified drug, but we still lack the evidence of 15-year presence in the EU market," said Ji Jianxin, a research manager with the drug's developer Di'ao Group based in southwest China's Sichuan Province.Di'ao, one of the largest Traditional Chinese Medicine (TCM) manufacturers, has been quite depressed, as many other TCM enterprises in China, by a European Union directive on traditional herbal medicinal products fully implemented from the beginning of this month.The directive requires that all herbal medicinal products, must obtain a medical license from any EU member state before it can be allowed in the EU market.It introduced a so-called simplified registration procedure with a seven-year transition period for traditional herbal medicinal products to be licensed, including Chinese and Indian ones.However, not a single Chinese herbal medicinal product has been granted the license so far, mainly due to the prohibitive registration cost and lack of required evidence to prove the product had a 30-year history of safe use, including 15 years in the EU.With a history of more than 2,000 years, TCM did not enter into the EU market until mid-1990s, and it has been imported into the EU and sold to European customers as food supplements instead of drugs.Most Chinese producers and importers did not reserve the customs papers a decade ago, thus unable to prove the 15-year use of their products in European markets.While TCM's globalization won't be doomed by one single EU directive as TCM export value to EU only takes up 14 percent of the total in 2010, experts and industry insiders still have had serious concerns about its future."Most TCM even don't have standardized labels that can help consumers to find out its origin," said Xian Sheng, from the China Association of TCM Export Companies.

MOSCOW, May 24 (Xinhua) -- Russia's Soyuz TMA-20 spacecraft with three crew members onboard has landed in Kazakhstan on Tuesday, said the Mission Control Center (MCC) outside Moscow.The spacecraft undocked from the International Space Station early Tuesday, carrying Russian cosmonaut Dmitry Kondratyev, European Space Agency (ESA) astronaut Paolo Nespoli and NASA astronaut Catherine Coleman back to Earth.According to the center, the Soyuz TMA-20 landed in the Kazakh steppe at 6:27 Moscow time (0227 GMT). Some 17 planes and helicopters and several rescue vehicles had conducted search works.Flight engineers Catherine "Cady" Coleman of the U.S. (L) and Italian Paolo Nespoli (R), and Russian cosmonaut and station commander Dmitry Kondratyev are seen after the Soyuz capsule landed, about 150 km (93 miles) southeast of the Kazakh town of Zhezkazgan May 24, 2011. A Russian Soyuz capsule delivered an international trio of astronauts back to Earth on Tuesday after six months on the International Space Station, parachuting through clear skies toward a safe landing on the Kazakh steppe.Deputy head of Federal Medical and Biological Agency Vyacheslav Rogozhkin said Italian astronaut Naspoli had some health problem after landing."Two crew members are fine, the third one has some problems with his vestibular system," Rogozhkin told a press conference after the landing.In December, the Soyuz TMA-20 was launched from the Kazakh Baikonur space center with three crew members.The next launch of manned spacecraft to the ISS was scheduled in early June.

BEIJING, May 24 (Xinhuanet) -- CT scan, a widely used heart-imaging test, is likely to result in the over treatment for patients with heart disease, according to a study published online by the Archives of Internal Medicine on Monday.CT, which produces a detailed image of the heart that reveals cholesterol buildups in the coronary arteries, is widely used in the hospital around the world."Testing might lead to more harm than good," said McEvoy, a doctor at Seoul National University Bundang Hospital in S. Korea.His team led the study, in which 2,000 healthy adults were divided into two groups. One thousand adults had CT scans and another half had standard tests, including routine checks of their blood pressure and cholesterol levels.After 18 months, the 215 people who had worrisome CT scans were advised to have additional tests and medical treatment, and some even advised to have surgery. But less than 10 percent in the group of standard test were reported to need medications.Therefore, physicians cannot easily ignore the diagnoses made by the new imaging techniques, McEvoy said, "We are left with the dilemma of what to do with the results,"According to McEvoy, doctors should focus on patients' lifestyle and traditional risk factors such as smoking and obesity.

来源：资阳报